ARTICLE SUMMARY:
JDRF’s philanthropic venture capital fund is focused on accelerating life-changing solutions to cure, prevent, and treat type 1 diabetes through catalytic commercial investment. It’s a unique solution that Fund Managing Director Katie Ellias believes will help spur innovation and bring new, disease-modifying therapies to patients more quickly.
Since its founding nearly 50 years ago, JDRF, formerly known as the Juvenile Diabetes Research Foundation, has been a staunch advocate for, and supporter of, early-stage research into treatments for type 1 diabetes (T1D).
